Antipsychotics for the management of Parkinson's disease psychosis

被引：2

作者：

Jethwa, Ketan Dipak ^{[1
]}

机构：

[1] Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Nottingham, England

来源：

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY | 2017年 / 32卷 / 04期

关键词：

D O I：

10.1002/gps.4640

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

引用

页码：464 / 465

页数：2

共 5 条

[1] Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial [J].

Cummings, Jeffrey ;

Isaacson, Stuart ;

Mills, Roger ;

Williams, Hilde ;

Chi-Burris, Kathy ;

Corbett, Anne ;

Dhall, Rohit ;

Ballard, Clive .

LANCET, 2014, 383 (9916) :533-540

[2]

Friedman J, 1999, NEW ENGL J MED, V340, P757

[3] Antipsychotics for the management of psychosis in Parkinson's disease: systematic review and meta-analysis [J].

Jethwa, Ketan Dipak ;

Onalaja, Oluwademilade A. .

BJPSYCH OPEN, 2015, 1 (01) :27-33

[4] Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis [J].

Meltzer, Herbert Y. ;

Mills, Roger ;

Revell, Stephen ;

Williams, Hilde ;

Johnson, Ann ;

Bahr, Daun ;

Friedman, Joseph H. .

NEUROPSYCHOPHARMACOLOGY, 2010, 35 (04) :881-892

[5] Clozapine in drug induced psychosis in Parkinson's disease:: a randomised, placebo controlled study with open follow up [J].

Pollak, P ;

Tison, F ;

Rascol, O ;

Destée, A ;

Péré, JJ ;

Senard, JM ;

Durif, F ;

Bourdeix, I .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (05) :689-695

← 1 →